Can we briefly talk about this Guanad O'Rellin and HCG?

Oh, yeah, yeah.

Before Steve tells us about this really interesting GLP thing, but briefly about this.

So you noticed, where did this come about?

I think the Pete Rubish mentioned it, his HRT clinic.

Can you tell us the background, Derek?

Yeah, so the HCG has like been reclassified as, I think it's like a biologic or something now.

I forget the exact thing that's happening.

And frankly, I stay more out of the backend stuff.

I'm more marketing front end stuff.

But as far as I know, it's a lot of these clinics, it's harder to get access to it, harder to get access now and or it's more expensive.

I don't really remember the exact reason, but I know that margins wise, they're getting more money now to sell this Gnadarellin stuff, which is a GnRH agonist, which if you're, you know, viewers are probably more

familiar with things like Triptorellin, things of that nature that operate in a similar way.

And basically the idea would be to, well, I guess the marketing angle that a lot of them are taking

or, oh, you don't want to take HCG because that's, you know, it's not natural. Whereas GnRH agonis, you're basically getting your whole HPTA involved

and you're, you know, mimicking what you would naturally do if you weren't shut down on TRT.

So with this, we can mimic the entire cycle of your HPTA and avoid, like we're not skipping

the part with the gonadotropin releasing hormone at the top.

We're actually getting the full spectrum of effects going and you're regulating how much LH and

FSAH output you get.

And it's indogynously produced LH and FSAH rather than a synthetic analog without any FSAH whatsoever.

So it's like logically it actually sort of sounds good.

...